Oscar Health, Inc. (OSCR) Q1 2024 Earnings Call Transcript

Oscar Health, Inc. (NYSE:OSCR) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET

Company Participants

Chris Potochar – Vice President-Treasury and Investor Relations
Mark Bertolini – Chief Executive Officer
Scott Blackley – Chief Financial Officer

Conference Call Participants

Stephen Baxter – Wells Fargo
Adam Ron – Bank of America
John Ransom – Raymond James
Josh Raskin – Nephron
Nathan Rich – Goldman Sachs

Operator

Good morning. My name is Ellie, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's First Quarter 2024 Earnings Conference Call. Please note that this call is being recorded. [Operator Instructions] Thank you.

I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations. Please go ahead.

Chris Potochar

Good evening, everyone. Thank you for joining us for our first quarter 2024 earnings call. Mark Bertolini, Oscar's Chief Executive Officer; and Scott Blackley, Oscar's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.

Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the period ended December 31, 2023, filed with the SEC and other filings with the SEC, including our quarterly report on Form 10-Q for the quarterly period ended March 31, 2024, to be filed with the SEC.

Such forward-looking